Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

ABBOTT LABORATORIES ABT

Abbott Laboratories is a global healthcare company. The Company is engaged in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment is engaged in the international sales of a broad line of branded generic pharmaceutical products. The Diagnostic Products segment is engaged in the worldwide sales of diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Nutritional Products segment is involved in the worldwide sales of a broad line of adult and pediatric nutritional products. The Medical Devices segment includes the worldwide sales of rhythm management, electrophysiology, heart failure, vascular, structural heart, neuromodulation, and diabetes care products.


NYSE:ABT - Post by User

Post by amaramurray21on Jun 28, 2021 4:24am
117 Views
Post# 33458528

Embolic Protection Devices Market Demand & Forecast by 2026

Embolic Protection Devices Market Demand & Forecast by 2026

According to the latest report by IMARC Group, titled “Embolic Protection Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026”, the global embolic protection devices market exhibited strong growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of 8.4% during 2021-2026.

We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Request Free Report Sample:

https://www.imarcgroup.com/embolic-protection-devices-market/requestsample

Embolic protection devices (EPDs) hold blood and luminal debris within the saphenous vein graft (SVG) while stenting to prevent distal embolization. These devices can be majorly classified into distal occlusion devices, distal filters, and proximal occlusion devices. EPDs are highly efficient in reducing periprocedural myocardial infarction (MI) and any adverse cardiovascular effects. They capture and remove debris that may get displaced during surgical procedures, such as SVG interventions, percutaneous coronary intervention, aortic valve stenosis, etc.

The high prevalence of cardiovascular diseases (CVDs), including cardiac arrests and other heart-related issues, are driving the market growth. EPDs mitigate various risks pertaining to several blockages in small blood vessels due to the debris released into the bloodstream. Besides this, the rising geriatric population, who are more vulnerable to chronic medical illnesses, is also inducing the demand for these devices. Additionally, several governments are heavily investing in various R&D activities for the development of advanced EPDs. The growing inclination towards minimally invasive surgeries has led to the launch of innovative medical tools for treating cardiovascular disorders. This is further anticipated to bolster the growth of the embolic protection devices (EPD) market in the coming years.

Embolic Protection Devices Market 2021-2026 Competitive Analysis and Segmentation:

Competitive Landscape with Key Players:

The competitive landscape of the global embolic protection devices market has been studied in the report with the detailed profiles of the key players operating in the market.

Some of these key players include:

 

  • Abbott Laboratories
  • Allium Medical Solutions Ltd.
  • Boston Scientific Corporation
  • Cardinal Health Inc.
  • Contego Medical LLC
  • Innovative Cardiovascular Solutions LLC
  • Edwards Lifesciences Corporation
  • Medtronic Inc.
  • Silk Road Medical Inc.

Key Market Segmentation:

The report has segmented the global embolic protection devices market on the basis of product, application, procedure, material, usage, end-user and region.

Breakup by Product:

  • Distal Filter Devices
  • Distal Occlusion Devices
  • Proximal Occlusion Devices

Breakup by Application:

  • Coronary Artery Treatment
  • Carotid Artery Treatment
  • Others

Breakup by Procedure:

  • Percutaneous Coronary Intervention
  • Carotid Artery Stenosis
  • Saphenous Vein Graft Intervention
  • Aortic Valve Stenosis (Transcatheter Aortic Valve Replacement)
  • Others

Breakup by Material:

  • Nitinol
  • Polyurethane

Breakup by Usage:

  • Disposable Devices
  • Re-Usable Devices

Breakup by End-User:

  • Hospitals and Clinics
  • Ambulatory Surgical Centers
  • Others

Breakup by Region:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • Middle East and Africa

Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/embolic-protection-devices-market

Key highlights of the report:            

  • Market Performance (2015-2020)
  • Market Outlook (2021-2026)
  • Industry Trends
  • Market Drivers and Success Factors
  • The Impact of COVID-19 on the Global Market
  • Value Chain Analysis
  • Structure of the Global Market
  • Comprehensive mapping of the competitive landscape

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

Browse Related Reports:

H1N1 Vaccines Market: https://www.imarcgroup.com/h1n1-vaccines-market

Healthcare IT Market: https://www.imarcgroup.com/healthcare-it-market

Healthcare Staffing Market: https://www.imarcgroup.com/healthcare-staffing-market

eHealth Market: https://www.imarcgroup.com/ehealth-market

GCC Implantable Medical Devices Market: https://www.imarcgroup.com/gcc-implantable-medical-devices-market

India Implantable Medical Devices Market: https://www.imarcgroup.com/india-implantable-medical-devices-market

Europe Implantable Medical Devices Market: https://www.imarcgroup.com/europe-implantable-medical-devices-market

Bone Densitometer Market: https://www.imarcgroup.com/bone-densitometer-market

Hearing Aid Market: https://www.imarcgroup.com/hearing-aid-market

Stem Cell Banking Market: https://www.imarcgroup.com/stem-cell-banking-market

About Us                              

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US:

IMARC Group
30 N Gould St, Ste R
Sheridan, WY 82801, USA
Email: sales@imarcgroup.com
Americas: +1-631-791-1145 | Europe & Africa: +44-753-713-2163 | Asia: +91-120-433-0800

 

 

 

 

<< Previous
Bullboard Posts
Next >>